Vistant Named to Inc. Mid-Atlantic List

2 years ago

With Revenue Growth of 200 Percent, Recognition Highlights Company’s Ongoing SuccessTOWSON, Md., March 14, 2023 (GLOBE NEWSWIRE) -- Vistant, a…

Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board

2 years ago

Professor Kranzler is the Benjamin Rush Professor of Psychiatry and Director of the Center for Studies of Addiction at the…

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

2 years ago

New Business Strategy Focused on Precision OncologyLONDON and HONG KONG, March 14, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:…

Roche Annual General Meeting 2023

2 years ago

All proposals of the Board of Directors approvedSeverin Schwan elected as new Chairman of the Board of Directors; all other…

357 Hemp Logistics’ President to Reveal Strategies for “Solving Logistics and Supply Chain Issues” at NoCo Hemp Expo, March 30th

2 years ago

The 357 Company Logistics issues can make or break a company. You can’t afford to miss the presentation on “Solving…

Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

2 years ago

SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools…

Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner

2 years ago

Comprehensive, multi-faceted IR program to focus on raising awareness of Predictive Oncology and its portfolio of unique, proprietary assets capable…

Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference

2 years ago

Presentation with live webcast today, March 14th at 10:40 AM ETDURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc.…

Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

2 years ago

Dr. Camille Bedrosian to continue employment as strategic development advisor with the company Eric Crombez, M.D. Eric Crombez, M.D.NOVATO, Calif.,…

Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering

2 years ago

SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on…